Yichang HEC Changjiang Pharmaceutical Co. Ltd. Announces Internal Dealings in Commercial Paper Amid Privatisation Efforts
Reuters
Jul 07
Yichang HEC Changjiang Pharmaceutical Co. Ltd. Announces Internal Dealings in Commercial Paper Amid Privatisation Efforts
Yichang Hec Changjiang Pharmaceutical Co. Ltd. announced internal dealings related to the privatization by way of merger. CICC Wealth Investment Limited, an exempt principal trader connected with the Offeror and owned by China International Capital Corporation Limited, disclosed dealings in other types of securities, including equity swaps. On 4 July 2025, the trader executed both purchase and sale transactions involving 1,200 shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on July 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.